Aquestive Therapeutics, Inc. (AQST)
NASDAQ: AQST · Real-Time Price · USD
4.200
-0.090 (-2.10%)
Mar 10, 2026, 4:00 PM EDT - Market closed
Aquestive Therapeutics Employees
Aquestive Therapeutics had 147 employees as of December 31, 2025. The number of employees increased by 5 or 3.52% compared to the previous year.
Employees
147
Change (1Y)
5
Growth (1Y)
3.52%
Revenue / Employee
$303,027
Profits / Employee
-$569,959
Market Cap
512.59M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 147 | 5 | 3.52% |
| Dec 31, 2024 | 142 | 7 | 5.19% |
| Dec 31, 2023 | 135 | 5 | 3.85% |
| Dec 31, 2022 | 130 | -27 | -17.20% |
| Dec 31, 2021 | 157 | -30 | -16.04% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2007 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2007 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Tilray Brands | 2,842 |
| Canopy Growth | 960 |
| Emergent BioSolutions | 900 |
| Organogenesis Holdings | 854 |
| Kamada | 420 |
| Evolus | 334 |
| Esperion Therapeutics | 304 |
| Akebia Therapeutics | 194 |
AQST News
- 1 day ago - Aquestive Therapeutics Announces Grant of Inducement Award Pursuant to Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 4 days ago - AQUESTIVE THERAPEUTICS, INC. (AQST) INVESTOR ALERT Investors With Large Losses in Aquestive Therapeutics, Inc. Should Contact Bernstein Liebhard LLP To Discuss Their Rights - GlobeNewsWire
- 4 days ago - AQST INVESTOR NOTICE: Faruqi & Faruqi, LLP Launches Investigation into Aquestive Therapeutics - Business Wire
- 5 days ago - Aquestive Therapeutics, Inc. (AQST) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 5 days ago - INVESTIGATION NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Aquestive Therapeutics - PRNewsWire
- 6 days ago - Aquestive Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 7 days ago - AQST SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Aquestive Therapeutics - GlobeNewsWire
- 10 days ago - AQST INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Aquestive Therapeutics - PRNewsWire